This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Test-Retest Reproducibility of 18F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network
- Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer
- Repeatability of SUV in Oncologic 18F-FDG PET
- Repeatability of Quantitative 18F-NaF PET: A Multicenter Study
- Prognostic Value of 68Ga-DOTANOC PET/CT SUVmax in Patients with Neuroendocrine Tumors of the Pancreas
- Multicenter Reproducibility of 18F-Fluciclatide PET Imaging in Subjects with Solid Tumors
- Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials
- 18F-FLT PET Evaluation of Radiation Response
- Repeatability of Quantitative FDG-PET/CT and Contrast-Enhanced CT in Recurrent Ovarian Carcinoma: Test-Retest Measurements for Tumor FDG Uptake, Diameter, and Volume
- Variability of Total Lesion Glycolysis by 18F-FDG-Positive Tissue Thresholding in Lung Cancer
- Using FDG-PET to Measure Early Treatment Response in Head and Neck Squamous Cell Carcinoma: Quantifying Intrinsic Variability in Order to Understand Treatment-Induced Change
- 18F-FDG Uptake by Metastatic Axillary Lymph Nodes on Pretreatment PET/CT as a Prognostic Factor for Recurrence in Patients with Invasive Ductal Breast Cancer
- Noise Considerations for PET Quantification Using Maximum and Peak Standardized Uptake Value
- Reproducibility of Tumor Uptake Heterogeneity Characterization Through Textural Feature Analysis in 18F-FDG PET
- Repeatability of 18F-FDG Uptake Measurements in Tumors: A Metaanalysis
- Coronary Arterial 18F-Sodium Fluoride Uptake: A Novel Marker of Plaque Biology
- Assessment of Valvular Calcification and Inflammation by Positron Emission Tomography in Patients With Aortic Stenosis
- Fluoroestradiol Positron Emission Tomography Reveals Differences in Pharmacodynamics of Aromatase Inhibitors, Tamoxifen, and Fulvestrant in Patients with Metastatic Breast Cancer
- Predictive Value of Initial 18F-FLT Uptake in Patients with Aggressive Non-Hodgkin Lymphoma Receiving R-CHOP Treatment
- Standardization of Quantitative Imaging: The Time Is Right, and 18F-FDG PET/CT Is a Good Place to Start
- Quantifying and Reducing the Effect of Calibration Error on Variability of PET/CT Standardized Uptake Value Measurements
- Phase II Study of Daily Sunitinib in FDG-PET-Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation
- Phenotyping of Tumor Biology in Patients by Multimodality Multiparametric Imaging: Relationship of Microcirculation, {alpha}v{beta}3 Expression, and Glucose Metabolism
- The future of imaging: developing the tools for monitoring response to therapy in oncology: the 2009 Sir James MacKenzie Davidson Memorial lecture
- Reproducibility of 18F-FDG and 3'-Deoxy-3'-18F-Fluorothymidine PET Tumor Volume Measurements
- Reproducibility of [11C]Choline-Positron Emission Tomography and Effect of Trastuzumab
- Standardized Uptake Values of 68Ga-DOTANOC PET: A Promising Prognostic Tool in Neuroendocrine Tumors
- Assessment of Interobserver Reproducibility in Quantitative 18F-FDG PET and CT Measurements of Tumor Response to Therapy
- Repeatability of 18F-FDG PET in a Multicenter Phase I Study of Patients with Advanced Gastrointestinal Malignancies
- Imaging of Proliferation in Hepatocellular Carcinoma with the In Vivo Marker 18F-Fluorothymidine
- Role of 18F-FDG PET in Assessment of Response in Non-Small Cell Lung Cancer
- Monitoring Predominantly Cytostatic Treatment Response with 18F-FDG PET
- Response to Therapy in Breast Cancer
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
- Measuring Response with FDG-PET: Methodological Aspects
- Tissue Classification as a Potential Approach for Attenuation Correction in Whole-Body PET/MRI: Evaluation with PET/CT Data
- Imaging Surrogates of Tumor Response to Therapy: Anatomic and Functional Biomarkers
- Comparison of Methods for Magnetic Resonance-Guided [18-F]Fluorodeoxyglucose Positron Emission Tomography in Human Carotid Arteries: Reproducibility, Partial Volume Correction, and Correlation Between Methods
- Reproducibility of Standardized Uptake Value Measurements Determined by 18F-FDG PET in Malignant Tumors
- In Vivo Characterization of Proliferation for Discriminating Cancer from Pancreatic Pseudotumors
- Analysis and Reproducibility of 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Imaging in Patients with Non-Small Cell Lung Cancer
- Detection of Neovessels in Atherosclerotic Plaques of Rabbits Using Dynamic Contrast Enhanced MRI and 18F-FDG PET
- Treatment Monitoring by 18F-FDG PET/CT in Patients with Sarcomas: Interobserver Variability of Quantitative Parameters in Treatment-Induced Changes in Histopathologically Responding and Nonresponding Tumors
- Use of H215O-PET and DCE-MRI to Measure Tumor Blood Flow
- Long-Term Precision of 18F-Fluoride PET Skeletal Kinetic Studies in the Assessment of Bone Metabolism
- Application of PET/CT in the Development of Novel Anticancer Drugs
- Imaging Gastric Cancer with PET and the Radiotracers 18F-FLT and 18F-FDG: A Comparative Analysis
- [18F]Galacto-RGD Positron Emission Tomography for Imaging of {alpha}v{beta}3 Expression on the Neovasculature in Patients with Squamous Cell Carcinoma of the Head and Neck
- 18F-FDG PET for Mediastinal Staging of Lung Cancer: Which SUV Threshold Makes Sense?
- Predicting Treatment Response of Malignant Gliomas to Bevacizumab and Irinotecan by Imaging Proliferation With [18F] Fluorothymidine Positron Emission Tomography: A Pilot Study
- 18Fluorodeoxyglucose Positron Emission Tomography Imaging of Atherosclerotic Plaque Inflammation Is Highly Reproducible: Implications for Atherosclerosis Therapy Trials
- Efficacy of imatinib mesylate in advanced medullary thyroid carcinoma
- Early Response Assessment Using 3'-Deoxy-3'-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma
- Partial-Volume Effect in PET Tumor Imaging
- Dynamic and Static Approaches to Quantifying 18F-FDG Uptake for Measuring Cancer Response to Therapy, Including the Effect of Granulocyte CSF
- Deep-Inspiration Breath-Hold PET/CT: Clinical Findings with a New Technique for Detection and Characterization of Thoracic Lesions
- Reproducibility of 18F-FDG microPET Studies in Mouse Tumor Xenografts
- Monitoring Cancer Treatment with PET/CT: Does It Make a Difference?
- Monitoring targeted therapy: is fluorodeoxylucose uptake a marker of early response?
- The Role of PET in Lymphoma
- High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy.
- Positron Emission Tomography As an Imaging Biomarker
- Positron Emission Tomography Using [18F]Galacto-RGD Identifies the Level of Integrin {alpha}v{beta}3 Expression in Man.
- Consensus Recommendations for the Use of 18F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials
- Prognostic Relevance of Response Evaluation Using [18F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Patients With Locally Advanced Non-Small-Cell Lung Cancer
- PET for response assessment in oncology: radiotherapy and chemotherapy
- Reproducibility of 3'-Deoxy-3'-18F-Fluorothymidine MicroPET Studies in Tumor Xenografts in Mice
- Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced-Stage Ovarian Cancer
- Early Prediction of Response to Chemotherapy in Metastatic Breast Cancer Using Sequential 18F-FDG PET
- 2-[11C]Thymidine Positron Emission Tomography Reproducibility in Humans
- Use of PET for Monitoring Cancer Therapy and for Predicting Outcome
- Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
- Application of Intravenous Contrast in PET/CT: Does It Really Introduce Significant Attenuation Correction Error?
- Effects of Noise, Image Resolution, and ROI Definition on the Accuracy of Standard Uptake Values: A Simulation Study
- Comparison of Different Quantitative Approaches to 18F-Fluoride PET Scans
- Simplified Kinetic Analysis of Tumor 18F-FDG Uptake: A Dynamic Approach
- Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment
- Respiratory Gating for 3-Dimensional PET of the Thorax: Feasibility and Initial Results
- Prediction of Response to Preoperative Chemotherapy in Gastric Carcinoma by Metabolic Imaging: Results of a Prospective Trial
- Positron Emission Tomography in Non-Small-Cell Lung Cancer: Prediction of Response to Chemotherapy by Quantitative Assessment of Glucose Use
- Cause and Magnitude of the Error Induced by Oral CT Contrast Agent in CT-Based Attenuation Correction of PET Emission Studies
- Functional imaging for assessment of therapy
- Prediction of Response to Preoperative Chemotherapy in Adenocarcinomas of the Esophagogastric Junction by Metabolic Imaging
- The Diagnostic Utility of the Lognormal Behavior of PET Standardized Uptake Values in Tumors